ZENITH Trial Findings Could Reshape PAH Treatment, Extending Sotatercept’s Reach
FDA Approves Durvalumab Combo for Muscle-Invasive Bladder Cancer
Sotatercept Reduces Risk of Death, Transplant, or Hospitalization in Advanced PAH
New FINEARTS-HF Findings Provide Clarity on Balancing Risk and Benefit in HF, CKD